High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
about
Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?Monogenic diabetes and pregnancyMetabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkersCirculating CD36 is reduced in HNF1A-MODY carriersPrevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studiesApproach to the patient with atypical diabetes.Low serum level of high-sensitivity C-reactive protein in a Japanese patient with maturity-onset diabetes of the young type 3 (MODY3).Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.Clinical features and treatment of maturity onset diabetes of the young (MODY).Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetesMutations in HNF1A result in marked alterations of plasma glycan profileEffects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.Monogenic diabetes: a diagnostic algorithm for cliniciansMutations in PCBD1 cause hypomagnesemia and renal magnesium wasting.The role of pancreatic imaging in monogenic diabetes mellitus.When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes.Chronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness.Clinical utility gene card for: Maturity-onset diabetes of the young.Comment on: McDonald et al. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 2011;34:1860-1862.Identification of circulating microRNAs in HNF1A-MODY carriers.RD Lawrence lecture 2012: assessing aetiology in diabetes: how C-peptide, CRP and fucosylation came to the party!Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862.Understanding childhood diabetes mellitus: new pathophysiological aspects.Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure.Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.The E3 SUMO ligase PIASγ is a novel interaction partner regulating the activity of diabetes associated hepatocyte nuclear factor-1α
P2860
Q26771916-389CD7DE-E6BC-440B-9C42-2F4BEB0F5082Q28066434-48B06190-1522-4365-9410-9DE87728D3F1Q28481662-0D51BB2F-88E5-4D04-954E-5DD9664523EFQ28533348-EB3E4A0C-337C-404E-BBD0-6F80308B3B4BQ30548217-57D551C6-D939-41E5-9F5B-57C1CC7BCFF3Q31120060-04B5F321-C592-460D-9712-7891A8EFEE20Q33728464-B8A12CDD-9468-498E-9781-49248852374DQ34299618-5BDABD2C-818D-4D0C-8874-DB993A68A9CCQ35563714-50FF6CFB-A2CA-4352-86BA-3FE64E22781DQ35997281-EB88B292-A92B-441B-96FD-8CC80763CDB5Q36157483-5660160D-362A-4D66-8383-ABA0528AA271Q36720490-8E3124E3-F00B-45CF-8BE6-E17556FB20F2Q37000827-75A326AB-0CA6-4513-9C90-67FF3DDB13D3Q37590415-CED043B8-ABB3-40E7-9C98-0695F6BDD7D8Q37604723-5897E667-259B-4066-BB94-49476C09862CQ37962349-D2FD1775-7E1E-4138-9844-655F11A1111EQ38816600-CDCA797C-DECE-4DA5-A3E2-B795F45FF13FQ41862149-1FCD6017-0452-4F77-A9E8-B42A7662B53AQ42796379-E9BF47D8-6AB4-4CA2-9B44-F8E546E5410AQ42974623-B4C8F93C-BB9B-4CB1-962D-C9B618871E9CQ43443137-8AF27F70-9D61-4C2D-9A13-397E80ACACC3Q43538580-E8D9F0FF-D5F3-4E80-9866-F83C41D148C1Q43805190-74A066BA-A56C-4EC9-9E42-462EE5BD05EBQ45905297-E622223F-EDBA-4942-B34E-5206FFED4958Q48106932-604FD76F-4012-41CA-A229-4FAD49648E51Q49885981-F97ABD2B-5BC5-4C21-AE69-3B99260A4AB1Q50057787-886896CE-D502-4BA2-86F1-3D185A14C73AQ51287966-F9154A66-67C0-4810-BF57-9CEC74E56B31Q58707539-2F13A10C-0504-487C-9021-724238391B35
P2860
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
@ast
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
@en
type
label
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
@ast
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
@en
prefLabel
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
@ast
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
@en
P2093
P2860
P50
P356
P1433
P1476
High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
@en
P2093
Beverley M Shields
Jane Lawry
Katharine R Owen
Tim J McDonald
P2860
P304
P356
10.2337/DC11-0323
P407
P577
2011-06-23T00:00:00Z